Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Aromatase inhibitors (AIs) have been associated with cardiovascular disease in adjuvant randomized controlled trials (RCTs) comparing these drugs to tamoxifen. However, it is unclear whether this risk is real or due to cardioprotective effects of tamoxifen. To address this question, we c...

Full description

Saved in:
Bibliographic Details
Published in:Ann Oncol
Main Authors: Khosrow-Khavar, F., Filion, K. B., Al-Qurashi, S., Torabi, N., Bouganim, N., Suissa, S., Azoulay, L.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Reviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834146/
https://ncbi.nlm.nih.gov/pubmed/27998966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw673
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items